Celsa, C., Nishida, N., Chamseddine, S., Arvind, A., Li, M., Toyoda, H., Ulahannan, S. V., Fulgenzi, C. A., Manfredi, G. F., D'Alessio, A., Stefanini, B., Cabibbo, G., Cammà, C., Scheiner, B., Rimassa, L., Kelley, R. K., Singal, A., Kaseb, A. O., Kudo, M., Pinato, D. J. (2025). Outcomes of durvalumab (D) with or without tremelimumab (T) in routine clinical practice according to HIMALAYA trial eligibility: Preliminary results of the international DT-real study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.552